| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |